Get smooth, radiant, and protected skin in one product
To ensure transparency and reliability, LeoLab submits selected GHK-Cu batches for third-party laboratory testing by independent analytical facilities
Manufactured by NOW Foods, this supplement is produced under strict GMP quality standards to ensure purity, potency, and consistency

CagriSema: The Proven Combination The cagrilintide and semaglutide combination (branded as CagriSema) represents the most clinically advanced cagrilintide-based combination therapy: Mechanism: Cagrilintide activates amylin receptors Semaglutide activates GLP-1 receptors only Two-pathway approach to weight management Clinical Results: 15.6% average weight loss in phase 3 trials Superior to semaglutide monotherapy (8.1% weight loss) Well-tolerated with manageable side effects Regulatory submissions completed in 2024 [9] Theoretical Advantages of Cagrilintide with Retatrutide A cagrilintide blend with retatrutide would theoretically offer several advantages over the CagriSema approach: Expanded Mechanism: Cagrilintide: Amylin receptor activation Retatrutide: GIP + GLP-1 + glucagon receptor activation Four-pathway approach versus two-pathway Potential Benefits: Greater weight loss magnitude (retatrutide alone achieved 24.2% vs semaglutide's ~15%) Enhanced energy expenditure through glucagon activation Improved metabolic flexibility from GIP effects Potentially superior glycemic control Comparison Table: For researchers interested in exploring various peptide combinations, understanding peptide blend research principles provides valuable foundational knowledge

That gives a simple heuristic: GLOW (3 peptides) the leaner base, chosen when skin is calm and the goal is straightforward skin-quality and recovery support
Using them in sequence (lighter AHK-Cu spray first, followed by GHK-Curich creams or serums) allows each peptide to optimize a different aspect of skin biology